Rezultati pretraživanja
  1. Our shares how changes to eligibility criteria will help more patients:

  2. prije 11 sati

    How simulation models can help change the future.

  3. Interested in participating in a at ? Here's a good starting point for discussions with your doctor and with the trained staff at the Patient Recruitment Office:

  4. is halted as fails test in South Africa - STAT

  5. prije 18 sati

    Alzheimers is a devastating diagnosis for people suffering from the disease, as well as their families, but a group of researchers feels that they are one step closer to finding a cure.

  6. 4. velj

    How important is ? Containing the latest is dependent upon the process to create an effective . Can Be Treated? to Undergo Human - Bloomberg

  7. 4. velj

    A new trial for the treatment of Alzheimer’s is due to begin in Europe and the United States as a new therapy for the incurable disease seeks global legitimacy: # Oligomannate # GreenValley

  8. Not what we hoped -- but we are determined to learn from what doesn’t work as well as what does work. halted administration of an investigational HIV vaccine in a after an interim review showed the regimen did not prevent

  9. 31. sij

    By volunteering for a at NIAAA, you can help advance the understanding and treatment of alcohol use disorder. Learn more about studies currently enrolling patients:

  10. 31. sij

    Drug molecule discovered by set to enter : time from discovery to trial start was 12 months vs the usual 4.5 years

  11. 31. sij
  12. 30. sij
  13. 30. sij
  14. 29. sij

    Planning on submitting an ongoing or completed to ? Procedures have been updated. Also the Advanced Search for trials in the system has new search fields. Go to for more information.

  15. A phase 1 is testing a new immunotherapy drug that targets a specific epitope -driven in head and neck cancers. Via

  16. 29. sij

    So pleased to see that this condition is getting the attention it deserves. Watch talk about a new to test the effectiveness of to treat . Starts at 8:20. Thanks

    Prikaži ovu nit
  17. 29. sij

    . reports on the FDA's agreement to an program for -assisted for while highlighting previous results, and speaks with about his experience participating in a study.

  18. has begun enrollment for the first human of a monoclonal antibody to prevent malaria. If successful, would offer short-term protection from malaria for medical workers, tourists, or military personnel traveling where malaria is common

  19. 18. sij
  20. 12. sij

    👈 results from CHOICES ph2 clinical trial...🥳 congrats to all involved in its development, recruitment, analysis and write-up!

    Prikaži ovu nit

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.